Sign in

CIK 0001750284 · Non-accelerated filer<br>Smaller reporting company

Olema Oncology, Inc.

Sign in to watch
Ticker
OLMA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
300409740
Phone
(415) 651-3316
Business address
365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Olema Pharmaceuticals, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 1,175,000 shares at $14.85 ($17,448,750)
  3. 4 Planned sale Director sold 25,000 shares at an average $10.30 ($257,450)
  4. 4 Option exercise CHIEF MEDICAL OFFICER acquired 9,460 shares (option exercise)
  5. 4 Planned sale Director sold 5,000 shares at $10.92 ($54,600)
  6. 4 Planned sale Director sold 15,000 shares at $9.51 ($142,650)
  7. 4 Planned sale Director sold 20,000 shares at $10.97 ($219,400)
  8. 4 Option exercise CHIEF MEDICAL OFFICER acquired 13,700 shares (option exercise)
  9. 4 Other disposition Director disposed of 481,014 shares (other)
  10. 4 Planned sale Director sold 25,000 shares at an average $12.41 ($310,309)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Planned sale Director sold 30,000 shares at an average $12.79 ($383,550)
  16. 4 Option exercise CHIEF MEDICAL OFFICER acquired 20,000 shares (option exercise)
  17. 4 Option exercise CH. OPERATING & FINANCIAL OFF. acquired 50,000 shares (option exercise)
  18. 4 Open-market sale Director sold 25,000 shares at an average $13.38 ($334,500)
  19. 4 Open-market buy Director bought 640,000 shares at an average $10.74 ($6,871,279)
  20. 4 Option exercise CH. OPERATING & FINANCIAL OFF. acquired 10,000 shares (option exercise)

Page 5 of 13 · 244 filings